Rainbow Children’s Medicare Board Approves Unaudited Financial Results for Q3 2026

Rainbow Children’s Medicare has announced the approval of its unaudited standalone and consolidated financial results for the third quarter of fiscal year 2026, ending December 31, 2025. The Board of Directors reviewed and approved these results during a meeting held on January 28, 2026. Key financial details and performance metrics are outlined in the official statement.

Financial Performance Highlights

The Board of Directors of Rainbow Children’s Medicare has approved the unaudited standalone and consolidated financial results for Q3 2026. Key figures from the standalone results include:

  • Total income reached ₹4,051.08 million.
  • Profit before tax stood at ₹884.34 million.
  • Profit after tax was reported as ₹658.24 million.

Consolidated Results Overview

The consolidated financial results provide a broader view of the company’s financial health. Notable figures from the consolidated results include:

  • Total income amounted to ₹4,559.61 million.
  • Profit before tax was ₹976.94 million.
  • Profit after tax reached ₹738.97 million.

Additional Key Developments

The Nomination and Remuneration Committee granted 100,000 stock options under the ESOP 2025 scheme to its eligible employees. Mr. Abrarali Dalal has been appointed as the Chief Executive Officer (CEO) of the Group, effective January 20, 2026.

Source: BSE

Previous Article

TVS Supply Chain Solutions Acquires Swamy & Sons 3PL to Enhance FMCG Logistics

Next Article

Manorama Industries Board Approves ₹460 Crore Capex Plan, Names New Executives